Pfizer: 2022 Global Hemophilia ASPIRE

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: Inquire within your unit

Memorial Deadline: Friday 29th, April 2022

External Deadline: Tuesday 3rd, May 2022


Description

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.

For all Investigator Sponsored Research (ISRs) and general research grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. Pfizer must not be involved in any aspect of study protocol or project development, nor the conduct or monitoring of the research program.

  • Additional information about the program can be found here.

Sponsor has extended deadline to May 3, 2022

 

 


Funding Sources

Pfizer Inc



This opportunity was posted by: RGCS

Last modified: March 17, 2022